2023 annual financial data
Silence Therapeutics 2023 Operating margin
Silence Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -195.48%.
Operating income was -49,604,000 GBP and net income was -43,267,000 GBP.
Operating cash flow was -39,350,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,375,000 GBP
- Operating income
- -49,604,000 GBP
- Net income
- -43,267,000 GBP
- Operating cash flow
- -39,350,000 GBP